Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015;11(5):259-266.
doi: 10.1007/s11888-015-0280-7.

The Increasing Relevance of Tumour Histology in Determining Oncological Outcomes in Colorectal Cancer

Affiliations
Review

The Increasing Relevance of Tumour Histology in Determining Oncological Outcomes in Colorectal Cancer

Iris D Nagtegaal et al. Curr Colorectal Cancer Rep. 2015.

Abstract

Colorectal cancer is not just one type of cancer. Differences in outcome and reaction to treatment can at least be partly explained by different histological and molecular subtypes. Recognition of these differences may influence treatment decisions. However, there is huge variation in the amount of information that is available. Several tumour types such as mucinous carcinoma, signet ring cell carcinoma, neuroendocrine carcinoma and adenosquamous carcinoma have such a distinct phenotype that they are readily recognised. However, due to the rarity of signet ring cell carcinoma and adenosquamous carcinoma, limited data are available. More recently defined subtypes, like medullary carcinoma, serrated adenocarcinoma and micropapillary carcinoma, are not adequately diagnosed, which limits research possibilities using large-scale data from registries. In the current review, we systematically describe the histologic subtypes with the clinical and molecular background. We evaluate their prognosis compared to adenocarcinoma not otherwise specified and speculate about the clinical relevance.

Keywords: Adenocarcinoma; Adenosquamous carcinoma; BRAF mutation; Colorectal cancer; Medullary carcinoma; Micropapillary carcinoma; Microsatellite instability; Mucinous carcinoma; Neuroendocrine carcinoma; Prognosis; RAS mutation; Serrated carcinoma; Signet ring cell carcinoma; Survival.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Different histological subtypes of colorectal cancer. a Mucinous carcinoma (MC), b signet ring cell carcinoma (SRCC), c neuroendocrine carcinoma (NEC), d adenosquamous carcinoma (ASC), e medullary carcinoma (MeC), f serrated carcinoma (SeC) and g micropapillary carcinoma (MiC)

References

    1. Hugen N, et al. Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factor. Int J Cancer. 2015;136(2):333–339. doi: 10.1002/ijc.28981. - DOI - PubMed
    1. Hugen N, et al. Metastatic pattern in colorectal cancer is strongly influenced by histological subtype. Ann Oncol. 2014;25(3):651–657. doi: 10.1093/annonc/mdt591. - DOI - PMC - PubMed
    1. Bosman FT, World Health Organization. International Agency for Research on Cancer . World Health Organization classification of tumours. 4. Lyon: International Agency for Research on Cancer; 2010.
    1. Nagtegaal I, et al. Morphological changes in tumour type after radiotherapy are accompanied by changes in gene expression profile but not in clinical behaviour. J Pathol. 2004;204(2):183–192. doi: 10.1002/path.1621. - DOI - PubMed
    1. Hyngstrom JR, et al. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base. Ann Surg Oncol. 2012;19(9):2814–2821. doi: 10.1245/s10434-012-2321-7. - DOI - PMC - PubMed

LinkOut - more resources